Organization Profile

You just read:

Affinium Pharmaceuticals Announces Qualified Infectious Disease Product (QIDP) Designation by the US FDA for AFN-1252 and Completion of Dosing of AFN-1720 Phase 1 Trial

News provided by

Affinium Pharmaceuticals

Nov 12, 2013, 00:44 ET